Tumor-fördernde Zielgene von BRAF und damit therapeutische Targets können von Seneszenz-auslösenden Zielgenen unterschieden werden
Year: 2023
Type: dissertation
Abstract: Malignant melanoma with its high metastatic potential and metastasis at early tumour stages is one of the deadliest cancers worldwide. Some melanocytic cells in BRAFV600E mutated nevi show the phenomenon of senescence, the absence of proliferative activity. Though, a small subset of these mutated nevi eventually evolves into malignant melanoma. Further mutations or molecular alterations in BRAF-dependent genes could either contribute to the maintenance of a senescence cell state or on the contrary be involved in malignant degeneration and tumour progression. To identify and further characterise these BRAF dependent genes, a variety of possible BRAF target genes was chosen and analysed due to BRAFV600E dependent expression. Analyses showed a striking connection between BRAFV600E mutation and the regulation of the gene AREG. BRAFV600E induces mRNA expression of AREG in wildtype BRAF NHEM, two wildtype BRAF melanoma cell lines and in one BRAFV600E mutated melanoma cell line. While protein levels where respectively increased in wildtype BRAF melanoma cell lines, we found AREG protein expression repressed in the melanoma cell line with endogenous BRAFV600E mutation. Tumour suppressive characteristics of AREG were found in AREG knockdown experiments. These findings can be supported by in silico analyses of patient data. AREG dependent induction of senescence in melanoma cell lines could not be proven.
Author: Seefried, Felix
Institution: Friedrich-Alexander-Universität Erlangen-Nürnberg
Language: German
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6996974384
